Posters
Confident Differentiation of <2% changes in Secondary Structure to Compare Batch-to-Batch Activity using Microfluidic Modulation Spectroscopy (MMS)
Dr Patrick King & Dr Mike Williams RedShiftBio & Susana De Jesús Acosta, Dr Roser Llevadot, BioKit
READ MOREMicrofluidic Modulation Spectroscopy for Protein Characterization A Case Study with EcoCRM, CRM197 Carrier Protein
Andrew Lees, Min-Ju Chang and Libo Wang
READ MOREPressure-perturbation of protein secondary structure coupled with Microfluidic Modulation Spectroscopy – a powerful platform for biopharmaceutical formulations development
Vera Gross, Gary Smejkal, Nicole Cutri, Alexander Lazarev (Pressure Biosciences) Libo Wang, John Linnan, Matthew McGann, Jeffrey Zonderman, (RedShiftBio)
READ MOREMicrofluidic Modulation Spectroscopy of a Biotherapeutic at Low to High Concentrations without Interference from Formulation Excipients
Libo Wang and Jeffrey Zonderman, RedShiftBio, and Ioannis A. Papayannopoulos and Shannon Renn-Bingham, Celldex
READ MOREComparability, Similarity, Linearity and High Order Structure Analysis of an IgG1 Sample by Microfluidic Modulation Spectroscopy
Libo Wang, Lucy Liu, Jason Rouse, Eugene Ma and Jeffery Zonderman RedShift BioAnalytics, Inc, Pfizer, Inc.
READ MOREHOS Study for IgG Samples Spiked with Different Amount of BSA by MMS
Libo Wang, RedShiftBio & Brent Kendrick, Elion Labs
READ MOREMicrofluidic Modulation Spectroscopy (MMS) – a novel automated infrared (IR) spectroscopic tool for secondary structure analysis of biopharmaceuticals with high sensitivity and repeatability
Dipanwita Batabyal, Harrison Lord, and Mats Wikström, Attribute Sciences, Amgen Inc, and Libo Wang, John Linnan and Jeffrey Zonderman,RedshiftBio
READ MORERepeatability , Concentration Linearity and High Order Structure Analysis of an IgG1 Sample by Microfluidic Modulation Spectroscopy (MMS)
Libo Wang, RedShiftBio & Lucy Liu, Pfizer
READ MORE